PHILADELPHIA, Jan. 19, 2017 /PRNewswire/ -- Industry acknowledgement is growing that adding highly personalized patient-centric services, efficient communications and coordination, as well as genuine hospitality to clinical trials, can greatly improve trial performance, according to Clincierge®. In the months since Clincierge's recognition as an innovator by the 2016 Clinical Informatics News "Best Practices" awards, the company has experienced over 700% business growth and now supports more than 45 global clinical studies representing 1,080 trial sites and more than 2,500 patients and their caregivers.
Scott Gray, Clincierge Chief Executive Officer, noted that Clincierge was engaged in 30 currently active global studies in disease indications ranging from rare diseases such as epidermolysis bullosa and Friedreich's ataxia, to those affecting many more people, such as Alzheimer's disease. Moreover, he said that many of the company's initial clients had added Clincierge's services and support to multiple additional studies around the world.
"Keeping patient recruitment and retention in clinical trials on schedule is a difficult problem that can lead to substantial delays in trial completion, cost over-runs, and negative impacts on the overall amount of evaluable data that can be submitted for regulatory reviews," said Mr. Gray. "We are clearly meeting a major need with our services and technology, which improve trial performance, transparency, and communications between stakeholders: patients, clinical trial site personnel, and trial sponsors and clinical research organizations."
Clincierge Presence at SCOPE
If you would like to know more about how Clincierge can improve the performance of your clinical trials, whether for rare or orphan diseases or for trials affecting larger numbers of patients, please visit our booth, #810, at the 8th Annual SCOPE Summit, taking place January 24-26, 2017 in Miami, Florida.
Clincierge® reduces barriers to clinical trial participation, enhancing enrollment and reducing drop-outs. We help put patient needs first, providing personalized support, travel and accommodation logistics, and directly paying trial-related costs outside of reimbursable incidental expenses. Live assistance in the patient's own language helps answer study-related questions or concerns. We readily address special needs and complex trial designs, building custom solutions to specific study-related problems. We operate worldwide in 30 countries and 20 languages, adding service areas and capabilities as needed. Our goal: to reduce clinical testing time and cost, thus helping get new treatments to market as swiftly as possible. For more information on our company and services, please visit our website at http://www.clincierge.com.
Gray Consulting International